| cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
| DB473368 | hippocampus | .a | 1 to 400 | 1 to 399 | tiling clone, | 399/494 (80 %) | 4 diff (99.2 %id) | ||
| NM_001144967.1 | .a | 1 to 8473 | 1 to 8473 | exact | RefSeq, | 8473/8473 (100 %) | 0 diff (100 %id) | ||
| DR006335 | Prostate | .a | 213 to 960 | 1 to 748 | 748/748 (100 %) | 4 diff (99.5 %id) | |||
| TI_1948087573 | .a | 274 to 1171 | 140 to 1043 | 904/1461 (61 %) | 39 diff (97.4 %id) | ||||
| TI_1948087735 | .a | 274 to 1087 | 137 to 950 | tiling clone, | 814/1427 (57 %) | 20 diff (98.6 %id) | |||
| TI_1948088087 | .a | 274 to 1087 | 133 to 949 | 811/1387 (58 %) | 7 diff (99.5 %id) | ||||
| AY312514 | .a | 275 to 3202 | 1 to 2928 | tiling clone, | 2928/2928 (100 %) | 2 diff (100.0 %id) | |||
| CV030811 | mixed | .a | 275 to 920 | 1 to 642 | 642/644 (99 %) | 9 diff (98.7 %id) | |||
| DC376664 | brain | .a | 309 to 802 | 68 to 561 | 494/561 (88 %) | 6 diff (99.0 %id) | |||
| DC377002 | brain | .a | 315 to 800 | 84 to 569 | 486/573 (84 %) | 8 diff (98.7 %id) | |||
| DA698104 | .a | 320 to 859 | 20 to 559 | capped | 540/558 (96 %) | 7 diff (98.8 %id) | |||
| AY243320 | lung | .a | 321 to 591 | 216 to 486 | 271/486 (55 %) | 6 diff (98.8 %id) | |||
| DC348039 | tongue, tumor tissue | .a | 322 to 741 | 137 to 556 | 420/540 (77 %) | 7 diff (98.8 %id) | |||
| DC376936 | brain | .a | 323 to 787 | 86 to 550 | 465/553 (84 %) | 8 diff (98.6 %id) | |||
| DC377093 | brain | .a | 323 to 789 | 86 to 552 | 467/552 (84 %) | 6 diff (99.0 %id) | |||
| DR002211 | fetal brain | .a | 340 to 1071 | 2 to 735 | 734/737 (99 %) | 7 diff (99.1 %id) | |||
| CN314396 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 386 to 883 | 45 to 542 | 498/542 (91 %) | 10 diff (98.2 %id) | |||
| BG476976 | melanotic melanoma, skin | .a | 574 to 1120 | 1 to 574 | 574/694 (82 %) | 37 diff (94.7 %id) | |||
| CN314401 | embryonic stem cells, DMSO-treated H9 cellline | .a | 577 to 1000 | 1 to 425 | 425/425 (100 %) | 1 diff (99.8 %id) | |||
| BE275776 | melanotic melanoma, skin | .a | 594 to 1179 | 1 to 583 | available from MGC, | 583/584 (99 %) | 4 diff (99.4 %id) | ||
| BE391640 | endometrium, adenocarcinoma cell line, uterus | .a | 613 to 1134 | 66 to 588 | available from MGC, | 523/588 (88 %) | 1 diff (99.9 %id) | ||
| CN314400 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 641 to 1153 | 1 to 514 | 514/514 (100 %) | 1 diff (99.9 %id) | |||
| DA033772 | .a | 656 to 1230 | 2 to 576 | capped | 575/575 (100 %) | 0 diff (100 %id) | |||
| BG468573 | adenocarcinoma cell line, colon | .a | 680 to 1542 | 1 to 858 | 858/858 (100 %) | 19 diff (97.8 %id) | |||
| DA723953 | .a | 715 to 960 | 2 to 248 | capped | 247/250 (98 %) | 4 diff (98.4 %id) | |||
| DA233323 | brain | .a | 719 to 1288 | 2 to 571 | capped | 570/570 (100 %) | 1 diff (99.9 %id) | ||
| DA804923 | brain | .a | 749 to 1277 | 2 to 530 | capped | 529/529 (100 %) | 0 diff (100 %id) | ||
| BP270109 | small intestine | .a | 901 to 1480 | 1 to 581 | 581/581 (100 %) | 4 diff (99.4 %id) | |||
| BI049817 | placenta_normal | .a | 922 to 1229 | 317 to 11 | 307/317 (96 %) | 1 diff (99.7 %id) | |||
| BF772767 | epid_tumor | .a | 927 to 1491 | 1 to 564 | 564/564 (100 %) | 6 diff (99.0 %id) | |||
| BX370160 | Placenta Cot 25-normalized | .a | 960 to 1268 | 13 to 325 | 313/422 (74 %) | 17 diff (96.0 %id) | |||
| CV376522 | testis_normal | .a | 1111 to 1325 | 216 to 2 | Submitted on the opposite strand | 215/216 (99 %) | 14 diff (93.6 %id) | ||
| DC310841 | cerebellum | .a | 1208 to 1787 | 1 to 580 | 580/580 (100 %) | 0 diff (100 %id) | |||
| EC496660 | Prostate | .a | 1267 to 1356 | 92 to 5 | 88/94 (93 %) | 1 diff (99.0 %id) | |||
| BG540865 | lung | .a | 1313 to 1927 | 1 to 611 | 611/920 (66 %) | 12 diff (98.7 %id) | |||
| BP333150 | salivary gland | .a | 1361 to 1938 | 1 to 578 | 578/578 (100 %) | 0 diff (100 %id) | |||
| BX490418 | .a | 1418 to 2032 | 1 to 615 | 615/615 (100 %) | 3 diff (99.6 %id) | ||||
| DA803839 | brain | .a | 1454 to 1997 | 2 to 545 | capped | 544/544 (100 %) | 0 diff (100 %id) | ||
| BG527782 | lung, mucoepidermoid carcinoma | .a | 1463 to 2149 | 1 to 687 | 687/687 (100 %) | 2 diff (99.8 %id) | |||
| BX486688 | .a | 1486 to 2182 | 1 to 697 | 697/697 (100 %) | 1 diff (99.9 %id) | ||||
| BP283351 | bone marrow | .a | 1487 to 2068 | 1 to 583 | 583/583 (100 %) | 7 diff (98.8 %id) | |||
| DA188888 | amygdala | .a | 1500 to 2057 | 2 to 559 | capped | 558/558 (100 %) | 1 diff (99.9 %id) | ||
| BG769727 | melanotic melanoma, high MDR (cell line), skin | .a | 1503 to 2403 | 1 to 915 | 873/918 (95 %) | 24 diff (97.4 %id) | |||
| DA186455 | amygdala | .a | 1511 to 2068 | 2 to 559 | capped | 558/558 (100 %) | 1 diff (99.9 %id) | ||
| DA376798 | thalamus | .a | 1522 to 1869 | 2 to 349 | capped | 348/348 (100 %) | 0 diff (100 %id) | ||
| BF690597 | melanotic melanoma, high MDR, skin | .a | 1522 to 2157 | 1 to 636 | 636/915 (69 %) | 16 diff (98.3 %id) | |||
| AW363240 | colon | .a | 1534 to 1908 | 13 to 395 | 383/428 (89 %) | 30 diff (93.0 %id) | |||
| BQ223500 | large cell carcinoma, lung | .a | 1551 to 2181 | 12 to 647 | 636/761 (83 %) | 21 diff (97.3 %id) | |||
| BF978511 | melanotic melanoma, high MDR, skin | .a | 1565 to 2284 | 1 to 722 | 722/848 (85 %) | 15 diff (98.3 %id) | |||
| BG496356 | lung, mucoepidermoid carcinoma | .a | 1570 to 2444 | 1 to 881 | 879/881 (99 %) | 22 diff (97.6 %id) | |||
| BF976829 | melanotic melanoma, high MDR, skin | .a | 1613 to 2334 | 1 to 726 | 727/858 (84 %) | 46 diff (94.7 %id) | |||
| BF697220 | brain, primitive neuroectoderm | .a | 1621 to 2223 | 1 to 605 | 605/858 (70 %) | 15 diff (98.3 %id) | |||
| BI862468 | breast, mammary adenocarcinoma, cell line | .a | 1651 to 2391 | 28 to 767 | 740/767 (96 %) | 9 diff (98.9 %id) | |||
| TI_57193343 | .a | 1651 to 2391 | 83 to 822 | 740/767 (96 %) | 9 diff (98.9 %id) | ||||
| BE961080 | melanotic melanoma, high MDR, skin | .a | 1677 to 2114 | 1 to 438 | 438/607 (72 %) | 15 diff (97.6 %id) | |||
| AI424022 | brain, glioblastoma (pooled) | .a | 1715 to 1829 | 115 to 1 | 115/115 (100 %) | 7 diff (94.0 %id) | |||
| BF979184 | melanotic melanoma, high MDR, skin | .a | 1745 to 2429 | 1 to 680 | 680/914 (74 %) | 11 diff (98.8 %id) | |||
| AU119079 | whole embryo, mainly head | .a | 1748 to 2525 | 2 to 780 | capped | 779/779 (100 %) | 7 diff (99.2 %id) | ||
| BF350618 | head_neck | .a | 1751 to 1958 | 1 to 206 | 206/208 (99 %) | 7 diff (96.7 %id) | |||
| BI051922 | placenta_normal | .a | 1753 to 2175 | 1 to 422 | 422/422 (100 %) | 1 diff (99.8 %id) | |||
| DA507391 | brain | .a | 1767 to 2316 | 2 to 550 | capped | 549/549 (100 %) | 1 diff (99.9 %id) | ||
| AW860568 | colon | .a | 1780 to 2111 | 14 to 344 | 331/344 (96 %) | 7 diff (98.0 %id) | |||
| AA838301 | colon, colon tumor | .a | 1812 to 2088 | 1 to 277 | 277/277 (100 %) | 0 diff (100 %id) | |||
| DA770969 | brain | .a | 1828 to 2411 | 2 to 585 | capped | 584/584 (100 %) | 2 diff (99.7 %id) | ||
| DA121210 | cerebellum | .a | 1849 to 2387 | 2 to 541 | capped | 540/540 (100 %) | 1 diff (99.9 %id) | ||
| DA021698 | .a | 1859 to 2438 | 2 to 581 | capped | 580/580 (100 %) | 0 diff (100 %id) | |||
| DA754970 | .a | 1865 to 2399 | 2 to 536 | capped | 535/535 (100 %) | 0 diff (100 %id) | |||
| CN314397 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 1992 to 2527 | 1 to 536 | 536/536 (100 %) | 0 diff (100 %id) | |||
| BF573210 | melanotic melanoma, high MDR, skin | .a | 2045 to 2622 | 1 to 573 | 573/872 (65 %) | 6 diff (99.4 %id) | |||
| CB152874 | Liver | .a | 2062 to 2604 | 1 to 543 | 543/543 (100 %) | 0 diff (100 %id) | |||
| AA469388 | .a | 2068 to 2431 | 1 to 364 | 364/364 (100 %) | 8 diff (97.9 %id) | ||||
| AA579307 | .a | 2068 to 2370 | 1 to 303 | 303/304 (99 %) | 7 diff (97.7 %id) | ||||
| BP316994 | pericardium | .a | 2068 to 2650 | 1 to 582 | 582/583 (99 %) | 11 diff (98.2 %id) | |||
| DA792115 | brain | .a | 2088 to 2642 | 2 to 555 | capped | 554/554 (100 %) | 1 diff (99.9 %id) | ||
| CB149311 | Liver | .a | 2098 to 2724 | 1 to 627 | 627/627 (100 %) | 1 diff (99.9 %id) | |||
| BX362375 | .a | 2108 to 2864 | 1 to 757 | 757/757 (100 %) | 60 diff (92.1 %id) | ||||
| BQ220579 | embryonal carcinoma, cell line, testis | .a | 2132 to 2930 | 1 to 804 | 804/864 (93 %) | 15 diff (98.3 %id) | |||
| BE799929 | lung, small cell carcinoma | .a | 2144 to 2802 | 1 to 674 | 674/952 (70 %) | 34 diff (96.5 %id) | |||
| DA781196 | brain | .a | 2170 to 2651 | 2 to 484 | capped | 483/483 (100 %) | 1 diff (99.8 %id) | ||
| FN116732 | breast carcinoma | .a | 2197 to 2297 | 1 to 103 | 103/103 (100 %) | 3 diff (97.1 %id) | |||
| BG122589 | adenocarcinoma, cell line, Liver | .a | 2198 to 2829 | 1 to 632 | 632/878 (71 %) | 13 diff (98.6 %id) | |||
| CF140426 | CNCAP(3)T-225 cell line, Prostate | .a | 2230 to 2541 | 8 to 320 | 313/320 (97 %) | 12 diff (96.3 %id) | |||
| T63391 | lung | .a | 2236 to 2338 | 1 to 103 | 103/109 (94 %) | 2 diff (98.2 %id) | |||
| BM694251 | eye, RPE and Choroid | .a | 2265 to 2726 | 1 to 462 | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 462/462 (100 %) | 0 diff (100 %id) | ||
| BP256830 | Kidney | .a | 2277 to 2858 | 1 to 582 | 582/582 (100 %) | 1 diff (99.9 %id) | |||
| BF748562 | breast_normal | .a | 2278 to 2650 | 34 to 402 | 369/404 (91 %) | 10 diff (97.6 %id) | |||
| AA469387 | .a | 2279 to 2626 | 380 to 33 | 347/380 (91 %) | 0 diff (100 %id) | ||||
| CB148891 | Liver | .a | 2281 to 2696 | 1 to 416 | 416/416 (100 %) | 2 diff (99.6 %id) | |||
| BG251196 | adenocarcinoma, cell line, Liver | .a | 2294 to 3101 | 1 to 794 | 796/966 (82 %) | 30 diff (96.9 %id) | |||
| BF689445 | melanotic melanoma, high MDR (cell line), skin | .a | 2296 to 2878 | 1 to 579 | fully sequenced, | 579/579 (100 %) | 2 diff (99.7 %id) | ||
| TI_1948087574 | .a | 2336 to 3197 | 858 to 1 | 859/1188 (72 %) | 33 diff (97.3 %id) | ||||
| BE077637 | breast | .a | 2363 to 2739 | 25 to 402 | 378/402 (94 %) | 10 diff (97.6 %id) | |||
| DA500284 | brain | .a | 2398 to 2971 | 2 to 575 | capped | 574/574 (100 %) | 0 diff (100 %id) | ||
| BX282031 | melanotic melanoma, skin | .a | 2426 to 2918 | 1 to 493 | 493/493 (100 %) | 0 diff (100 %id) | |||
| BQ215431 | melanotic melanoma, skin | .a | 2428 to 3266 | 1 to 844 | 844/845 (99 %) | 9 diff (99.0 %id) | |||
| DA505908 | brain | .a | 2440 to 2985 | 2 to 548 | capped | 547/547 (100 %) | 1 diff (99.9 %id) | ||
| BE708370 | head_neck | .a | 2442 to 2706 | 284 to 19 | 266/284 (93 %) | 1 diff (99.7 %id) | |||
| DA513862 | brain | .a | 2482 to 3033 | 2 to 553 | capped | 552/552 (100 %) | 1 diff (99.9 %id) | ||
| BE091676 | breast | .a | 2494 to 2815 | 1 to 322 | 322/322 (100 %) | 3 diff (99.1 %id) | |||
| BG761215 | melanotic melanoma, high MDR (cell line), skin | .a | 2508 to 3443 | 1 to 948 | 948/970 (97 %) | 29 diff (97.1 %id) | |||
| TI_1948087736 | .a | 2524 to 3205 | 810 to 127 | 684/1365 (50 %) | 13 diff (99.1 %id) | ||||
| TI_1948088088 | .a | 2524 to 3205 | 811 to 126 | 686/1354 (50 %) | 12 diff (99.2 %id) | ||||
| AA341248 | Kidney | .a | 2577 to 2882 | 9 to 314 | 306/314 (97 %) | 6 diff (98.1 %id) | |||
| BG546670 | lung | .a | 2581 to 3088 | 1 to 507 | 507/507 (100 %) | 1 diff (99.9 %id) | |||
| H06012 | whole brain | .a | 2587 to 2884 | 1 to 298 | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 298/298 (100 %) | 0 diff (100 %id) | ||
| BE391083 | endometrium, adenocarcinoma cell line, uterus | .a | 2615 to 3185 | 1 to 571 | 571/572 (99 %) | 1 diff (99.9 %id) | |||
| BE390022 | endometrium, adenocarcinoma cell line, uterus | .a | 2616 to 3225 | 1 to 609 | 609/611 (99 %) | 4 diff (99.4 %id) | |||
| DA510755 | brain | .a | 2620 to 3189 | 2 to 572 | capped | 571/571 (100 %) | 1 diff (99.9 %id) | ||
| R19498 | whole brain | .a | 2645 to 3018 | 1 to 374 | 374/374 (100 %) | 2 diff (99.5 %id) | |||
| TI_149309079 | .a | 2646 to 3508 | 937 to 85 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 853/970 (87 %) | 15 diff (98.5 %id) | ||
| BG534244 | lung | .a | 2663 to 3320 | 1 to 666 | 666/666 (100 %) | 34 diff (94.9 %id) | |||
| T74302 | whole brain | .a | 2665 to 3187 | 1 to 526 | 524/528 (99 %) | 9 diff (98.3 %id) | |||
| BE792440 | lung, small cell carcinoma | .a | 2673 to 3370 | 1 to 697 | tiling clone, | 697/697 (100 %) | 2 diff (99.8 %id) | ||
| R07229 | liver and spleen | .a | 2676 to 3023 | 1 to 365 | 365/382 (95 %) | 17 diff (95.6 %id) | |||
| W87678 | liver and spleen | .a | 2676 to 3146 | 1 to 479 | 477/479 (99 %) | 8 diff (98.4 %id) | |||
| BM853023 | Ascites, stomach | .a | 2701 to 3226 | 1 to 525 | 525/525 (100 %) | 5 diff (99.1 %id) | |||
| BX330935 | .a | 2706 to 3484 | 783 to 1 | 783/783 (100 %) | 31 diff (96.1 %id) | ||||
| DA796647 | brain | .a | 2715 to 3280 | 2 to 568 | capped | 567/567 (100 %) | 2 diff (99.7 %id) | ||
| BX327480 | .a | 2730 to 3507 | 1 to 777 | 777/778 (99 %) | 5 diff (99.4 %id) | ||||
| TI_159719850 | .a | 2736 to 3521 | 915 to 132 | 784/1084 (72 %) | 22 diff (98.0 %id) | ||||
| TI_158432766 | .a | 2753 to 3507 | 838 to 86 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 753/917 (82 %) | 17 diff (98.2 %id) | ||
| TI_157599955 | .a | 2762 to 3507 | 832 to 88 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 745/791 (94 %) | 6 diff (99.3 %id) | ||
| DA172946 | amygdala | .a | 2793 to 3365 | 2 to 574 | capped | 573/573 (100 %) | 0 diff (100 %id) | ||
| DA786348 | brain | .a | 2793 to 3370 | 2 to 579 | capped | 578/578 (100 %) | 0 diff (100 %id) | ||
| CB108717 | Liver | .a | 2794 to 3281 | 1 to 488 | 488/488 (100 %) | 0 diff (100 %id) | |||
| TI_154099689 | .a | 2797 to 3513 | 783 to 63 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 721/722 (99 %) | 10 diff (98.7 %id) | ||
| AI810999 | Prostate | .a | 2798 to 2894 | 97 to 1 | 97/97 (100 %) | 2 diff (98.0 %id) | |||
| BM999213 | lung, Lung Focal Fibrosis | .a | 2804 to 3428 | 19 to 637 | Submitted on the opposite strand | 619/623 (99 %) | 9 diff (98.6 %id) | ||
| BU687509 | lung | .a | 2804 to 3508 | 724 to 19 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 706/706 (100 %) | 1 diff (99.9 %id) | |
| TI_149276618 | .a | 2820 to 3515 | 786 to 91 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 696/893 (77 %) | 2 diff (99.8 %id) | ||
| BU677301 | lung, Primary Lung Epithelial Cells | .a | 2844 to 3515 | 688 to 17 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 672/672 (100 %) | 1 diff (99.9 %id) | |
| BF690387 | melanotic melanoma, high MDR (cell line), skin | .a | 2848 to 3592 | 746 to 1 | fully sequenced, | 746/746 (100 %) | 13 diff (98.3 %id) | ||
| AA443004 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 2853 to 3288 | 1 to 436 | fully sequenced, | 436/436 (100 %) | 2 diff (99.6 %id) | ||
| BM714998 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 2876 to 3506 | 1 to 631 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 631/631 (100 %) | 0 diff (100 %id) | |
| AA621164 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 2879 to 3509 | 640 to 11 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 630/630 (100 %) | 13 diff (98.0 %id) | |
| CA441150 | Fibrosarcoma | .a | 2906 to 3513 | 628 to 19 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 610/610 (100 %) | 2 diff (99.7 %id) | |
| CF529208 | placenta | .a | 2909 to 3507 | 617 to 19 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 599/599 (100 %) | 0 diff (100 %id) | |
| TI_149307514 | .a | 2928 to 3506 | 667 to 91 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 577/962 (59 %) | 16 diff (98.4 %id) | ||
| AW873034 | adrenal gland, neuroblastoma | .a | 2931 to 3517 | 587 to 1 | 587/591 (99 %) | 2 diff (99.7 %id) | |||
| CF528594 | placenta | .a | 2937 to 3507 | 588 to 18 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 571/571 (100 %) | 0 diff (100 %id) | |
| BQ008198 | Chondrosarcoma, Left Pubic Bone | .a | 2940 to 3635 | 709 to 19 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 691/695 (99 %) | 5 diff (99.3 %id) | |
| AA778109 | heart | .a | 2968 to 3507 | 551 to 13 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 539/539 (100 %) | 12 diff (97.8 %id) | |
| CB113084 | Liver | .a | 2977 to 3234 | 1 to 258 | 258/258 (100 %) | 3 diff (98.9 %id) | |||
| AW952846 | .a | 2986 to 3508 | 524 to 1 | Submitted on the opposite strand | 524/524 (100 %) | 3 diff (99.5 %id) | |||
| BP239924 | Liver | .a | 3006 to 3620 | 1 to 615 | 615/615 (100 %) | 7 diff (98.9 %id) | |||
| BG122854 | adenocarcinoma, cell line, Liver | .a | 3017 to 3659 | 1 to 644 | 644/946 (68 %) | 10 diff (99.0 %id) | |||
| AA278729 | germinal center B cell | .a | 3033 to 3446 | 414 to 1 | 414/415 (99 %) | 4 diff (99.1 %id) | |||
| DB542138 | hippocampus | .a | 3039 to 3515 | 1 to 477 | Submitted on the opposite strand | 477/477 (100 %) | 1 diff (99.8 %id) | ||
| AW471484 | colon, moderately-differentiated adenocarcinoma | .a | 3039 to 3509 | 471 to 1 | 471/472 (99 %) | 0 diff (100 %id) | |||
| BU733122 | eye, RPE and Choroid | .a | 3041 to 3509 | 487 to 19 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 469/469 (100 %) | 1 diff (99.8 %id) | |
| BM719578 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 3047 to 3517 | 1 to 471 | fully sequenced, | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 471/471 (100 %) | 1 diff (99.8 %id) | |
| BM931700 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 3047 to 3515 | 1 to 469 | fully sequenced, | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 469/469 (100 %) | 0 diff (100 %id) | |
| BP256666 | Kidney | .a | 3056 to 3638 | 1 to 583 | 583/583 (100 %) | 0 diff (100 %id) | |||
| BM676699 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 3069 to 3506 | 457 to 19 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 439/439 (100 %) | 1 diff (99.8 %id) | |
| AA610291 | breast | .a | 3077 to 3506 | 433 to 4 | 430/433 (99 %) | 0 diff (100 %id) | |||
| BU558238 | adenocarcinoma, cell line, breast | .a | 3078 to 3506 | 1 to 430 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 430/430 (100 %) | 5 diff (98.9 %id) | |
| EC536489 | Prostate | .a | 3083 to 3184 | 1 to 101 | 101/101 (100 %) | 3 diff (97.1 %id) | |||
| EC520451 | Prostate | .a | 3085 to 3184 | 1 to 97 | 97/97 (100 %) | 3 diff (97.0 %id) | |||
| C75504 | .a | 3097 to 3511 | 413 to 4 | 410/414 (99 %) | 0 diff (100 %id) | ||||
| AU145505 | whole embryo, mainly head | .a | 3097 to 3635 | 534 to 1 | 534/581 (91 %) | 8 diff (98.7 %id) | |||
| AW352301 | head_neck | .a | 3099 to 3417 | 21 to 337 | 317/337 (94 %) | 6 diff (98.3 %id) | |||
| AW352302 | head_neck | .a | 3099 to 3417 | 317 to 1 | 317/320 (99 %) | 2 diff (99.4 %id) | |||
| BF349410 | head_neck | .a | 3099 to 3403 | 315 to 12 | 304/318 (95 %) | 0 diff (100 %id) | |||
| AA530951 | normal prostatic epithelial cells, Prostate | .a | 3099 to 3401 | 307 to 1 | 307/311 (98 %) | 11 diff (96.5 %id) | |||
| DB537317 | hippocampus | .a | 3100 to 3515 | 1 to 416 | Submitted on the opposite strand | 416/416 (100 %) | 3 diff (99.3 %id) | ||
| AI357376 | brain, glioblastoma (pooled) | .a | 3100 to 3506 | 418 to 11 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 408/691 (59 %) | 13 diff (98.2 %id) | |
| AW386064 | pnet | .a | 3103 to 3252 | 1 to 150 | 150/150 (100 %) | 3 diff (98.0 %id) | |||
| BE928585 | denis_drash | .a | 3103 to 3252 | 1 to 150 | 150/150 (100 %) | 3 diff (98.0 %id) | |||
| AI240561 | liver and spleen | .a | 3104 to 3511 | 410 to 3 | 408/410 (99 %) | 0 diff (100 %id) | |||
| AA743916 | Kidney | .a | 3113 to 3629 | 517 to 1 | 517/517 (100 %) | 5 diff (99.1 %id) | |||
| AI383935 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 3114 to 3509 | 406 to 11 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 396/396 (100 %) | 0 diff (100 %id) | |
| AI805240 | Prostate | .a | 3114 to 3515 | 402 to 1 | 402/402 (100 %) | 0 diff (100 %id) | |||
| AW235527 | Kidney | .a | 3114 to 3518 | 408 to 4 | 405/408 (99 %) | 0 diff (100 %id) | |||
| BF740124 | brain, glioblastoma (pooled) | .a | 3114 to 3506 | 393 to 1 | 393/393 (100 %) | 1 diff (99.8 %id) | |||
| AI950165 | anaplastic oligodendroglioma, brain | .a | 3116 to 3511 | 414 to 19 | 396/414 (95 %) | 0 diff (100 %id) | |||
| BF349406 | head_neck | .a | 3119 to 3417 | 1 to 297 | 297/297 (100 %) | 2 diff (99.4 %id) | |||
| BP260852 | small intestine | .a | 3130 to 3704 | 1 to 575 | tiling clone, | 575/575 (100 %) | 2 diff (99.7 %id) | ||
| BG399173 | Kidney | .a | 3132 to 3657 | 1 to 525 | 525/805 (65 %) | 4 diff (99.6 %id) | |||
| AI377528 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 3133 to 3517 | 385 to 1 | 385/385 (100 %) | 0 diff (100 %id) | |||
| BM998044 | lung, Metastatic Chondrosarcoma | .a | 3139 to 3635 | 515 to 19 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 497/497 (100 %) | 0 diff (100 %id) | |
| AI202695 | Prostate | .a | 3140 to 3629 | 490 to 1 | 490/490 (100 %) | 0 diff (100 %id) | |||
| EC555523 | Prostate | .a | 3155 to 3256 | 1 to 101 | 101/105 (96 %) | 3 diff (97.2 %id) | |||
| W87762 | liver and spleen | .a | 3163 to 3506 | 344 to 1 | 344/345 (99 %) | 5 diff (98.6 %id) | |||
| CN314398 | embryonic stem cells, DMSO-treated H9 cellline | .a | 3165 to 3515 | 1 to 351 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 351/351 (100 %) | 4 diff (98.9 %id) | |
| BE275030 | melanotic melanoma, skin | .a | 3169 to 3511 | 1 to 343 | 343/345 (99 %) | 1 diff (99.8 %id) | |||
| AI868734 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 3170 to 3509 | 340 to 1 | 340/340 (100 %) | 0 diff (100 %id) | |||
| C15964 | .a | 3171 to 3471 | 1 to 300 | 300/300 (100 %) | 2 diff (99.4 %id) | ||||
| AI670111 | Prostate | .a | 3177 to 3639 | 465 to 3 | 463/465 (99 %) | 0 diff (100 %id) | |||
| R07177 | liver and spleen | .a | 3180 to 3507 | 335 to 4 | 332/337 (98 %) | 0 diff (100 %id) | |||
| BF589563 | Prostate | .a | 3186 to 3635 | 452 to 3 | 450/452 (99 %) | 0 diff (100 %id) | |||
| TI_57242470 | .a | 3191 to 3660 | 24 to 493 | 470/827 (56 %) | 4 diff (99.6 %id) | ||||
| AA443082 | .a | 3195 to 3587 | 1 to 392 | 392/392 (100 %) | 1 diff (99.8 %id) | ||||
| BI917877 | brain | .a | 3196 to 3660 | 1 to 465 | 465/799 (58 %) | 4 diff (99.5 %id) | |||
| BQ679080 | melanotic melanoma, cell line, skin | .a | 3197 to 3509 | 1 to 313 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 313/313 (100 %) | 0 diff (100 %id) | |
| AA737673 | germinal center B cell | .a | 3213 to 3639 | 430 to 5 | 426/430 (99 %) | 0 diff (100 %id) | |||
| AA825696 | germinal center B cell | .a | 3236 to 3639 | 408 to 5 | 404/408 (99 %) | 0 diff (100 %id) | |||
| AI826248 | normal prostate, Prostate | .a | 3238 to 3629 | 415 to 24 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 392/392 (100 %) | 1 diff (99.8 %id) | |
| AA564169 | normal prostate, Prostate | .a | 3251 to 3510 | 258 to 1 | 258/258 (100 %) | 2 diff (99.3 %id) | |||
| AA463445 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 3258 to 3519 | 260 to 1 | fully sequenced, | 260/260 (100 %) | 7 diff (97.4 %id) | ||
| BM675510 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 3292 to 3515 | 242 to 19 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 224/224 (100 %) | 0 diff (100 %id) | |
| AI961598 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .a | 3293 to 3636 | 343 to 1 | 343/343 (100 %) | 1 diff (99.8 %id) | |||
| BM682883 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 3293 to 3515 | 242 to 19 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 224/224 (100 %) | 1 diff (99.6 %id) | |
| AI434837 | Kidney | .a | 3298 to 3637 | 341 to 1 | 341/341 (100 %) | 3 diff (99.2 %id) | |||
| BG272030 | normal head/neck tissue | .a | 3308 to 3505 | 261 to 64 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 198/223 (88 %) | 0 diff (100 %id) | |
| BU072968 | insulinoma, Pancreas | .a | 3312 to 3839 | 3 to 529 | fully sequenced, | 527/529 (99 %) | 6 diff (98.9 %id) | ||
| AA705020 | liver and spleen | .a | 3326 to 3506 | 181 to 2 | 180/181 (99 %) | 0 diff (100 %id) | |||
| T63535 | lung | .a | 3340 to 3465 | 129 to 3 | 127/129 (98 %) | 0 diff (100 %id) | |||
| BE327823 | malignant melanoma, metastatic to lymphnode, skin | .a | 3343 to 3509 | 181 to 13 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 169/170 (99 %) | 5 diff (97.1 %id) | |
| AW992108 | breast_normal | .a | 3354 to 3575 | 1 to 222 | 222/222 (100 %) | 2 diff (99.1 %id) | |||
| BF816627 | colon_ins | .a | 3374 to 3923 | 553 to 6 | Submitted on the opposite strand | 548/553 (99 %) | 37 diff (93.4 %id) | ||
| AV727203 | hypothalamus | .a | 3386 to 4044 | 1 to 661 | 661/661 (100 %) | 14 diff (97.9 %id) | |||
| EC446361 | Prostate | .a | 3399 to 3506 | 118 to 11 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 108/108 (100 %) | 3 diff (97.3 %id) | |
| T25138 | .a | 3403 to 3507 | 107 to 4 | 104/107 (97 %) | 0 diff (100 %id) | ||||
| DA082744 | cerebellum | .a | 3403 to 3978 | 2 to 579 | capped | 578/578 (100 %) | 2 diff (99.7 %id) | ||
| H05963 | whole brain | .a | 3410 to 3635 | 246 to 21 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 226/226 (100 %) | 2 diff (99.2 %id) | |
| EC577811 | Prostate | .a | 3412 to 3515 | 102 to 1 | 102/102 (100 %) | 2 diff (98.1 %id) | |||
| BG055218 | Prostate | .a | 3425 to 3639 | 219 to 5 | 215/219 (98 %) | 0 diff (100 %id) | |||
| AW630620 | 2 pooled high-grade transitional celltumors, genitourinary tract | .a | 3437 to 3864 | 1 to 429 | 429/429 (100 %) | 1 diff (99.8 %id) | |||
| EC527519 | Prostate | .a | 3450 to 3506 | 1 to 58 | 58/59 (98 %) | 3 diff (95.0 %id) | |||
| AF070601 | brain | .a | 3468 to 5090 | 1 to 1624 | tiling clone, AAA | Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) | 1624/1624 (100 %) | 3 diff (99.9 %id) | |
| EC553758 | Prostate | .a | 3469 to 3569 | 96 to 1 | 96/101 (95 %) | 7 diff (93.1 %id) | |||
| BQ000605 | Fibrosarcoma | .a | 3530 to 4337 | 819 to 19 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 801/804 (99 %) | 8 diff (99.1 %id) | |
| AA902439 | carcinoid, lung | .a | 3659 to 4075 | 1 to 417 | Submitted on the opposite strand | 417/417 (100 %) | 1 diff (99.8 %id) | ||
| T82420 | lung | .a | 3660 to 3892 | 1 to 236 | 236/236 (100 %) | 3 diff (98.8 %id) | |||
| AI700448 | pooled | .a | 3660 to 4179 | 1 to 521 | Submitted on the opposite strand | 521/521 (100 %) | 4 diff (99.3 %id) | ||
| DA416288 | thalamus | .a | 3667 to 4199 | 2 to 534 | capped | 533/533 (100 %) | 1 diff (99.9 %id) | ||
| AI247502 | liver and spleen | .a | 3682 to 4031 | 1 to 350 | Submitted on the opposite strand | 350/350 (100 %) | 1 diff (99.8 %id) | ||
| H54325 | liver and spleen | .a | 3711 to 4081 | 1 to 372 | Submitted on the opposite strand | 372/377 (98 %) | 2 diff (99.5 %id) | ||
| AI222939 | carcinoid, lung | .a | 3714 to 4139 | 1 to 426 | Submitted on the opposite strand | 426/426 (100 %) | 1 diff (99.8 %id) | ||
| BU070956 | insulinoma, Pancreas | .a | 3809 to 4327 | 547 to 30 | fully sequenced, AAA | 518/529 (97 %) | 5 diff (99.1 %id) | ||
| CA312089 | Human Lung Epithelial cells, lung | .a | 3818 to 4494 | 695 to 19 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 677/677 (100 %) | 0 diff (100 %id) | |
| CB120066 | Liver | .a | 3819 to 4267 | 1 to 449 | 449/449 (100 %) | 1 diff (99.8 %id) | |||
| DB560788 | hypothalamus | .a | 3881 to 4337 | 1 to 457 | Submitted on the opposite strand | 457/457 (100 %) | 8 diff (98.3 %id) | ||
| U57844 | eye | .a | 3886 to 4645 | 1 to 762 | 762/762 (100 %) | 3 diff (99.7 %id) | |||
| R52394 | whole brain | .a | 3886 to 4275 | 1 to 392 | 392/392 (100 %) | 4 diff (99.0 %id) | |||
| BF207897 | bladder, carcinoma, cell line | .a | 3904 to 4619 | 1 to 708 | 708/708 (100 %) | 26 diff (96.4 %id) | |||
| TI_149283582 | .a | 3906 to 4584 | 774 to 96 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 679/679 (100 %) | 2 diff (99.8 %id) | ||
| BU680215 | lung, Primary Lung Epithelial Cells | .a | 3927 to 4584 | 674 to 17 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 658/658 (100 %) | 0 diff (100 %id) | |
| DA800863 | brain | .a | 4008 to 4501 | 2 to 496 | capped | 495/495 (100 %) | 1 diff (99.8 %id) | ||
| EC565798 | Prostate | .a | 4015 to 4122 | 9 to 116 | 108/116 (93 %) | 0 diff (100 %id) | |||
| AV749561 | Pituitary | .a | 4072 to 4612 | 1 to 540 | 540/547 (98 %) | 19 diff (96.6 %id) | |||
| BM930532 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 4078 to 4590 | 520 to 8 | Submitted on the opposite strand | 513/523 (98 %) | 0 diff (100 %id) | ||
| TI_151761684 | .a | 4078 to 4596 | 61 to 580 | Submitted on the opposite strand | 520/982 (52 %) | 6 diff (99.4 %id) | |||
| FN073799 | breast carcinoma | .a | 4153 to 4205 | 53 to 1 | Submitted on the opposite strand | 53/54 (98 %) | 0 diff (100 %id) | ||
| AL533812 | brain, fetal brain | .a | 4164 to 5090 | 1 to 927 | AAA | Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) | 927/927 (100 %) | 2 diff (99.8 %id) | |
| D12450 | Liver | .a | 4177 to 4330 | 12 to 165 | 154/165 (93 %) | 6 diff (96.4 %id) | |||
| AA234837 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 4188 to 4593 | 1 to 406 | 406/406 (100 %) | 0 diff (100 %id) | |||
| FN132570 | breast carcinoma | .a | 4207 to 4290 | 1 to 85 | 85/85 (100 %) | 5 diff (94.2 %id) | |||
| R43846 | whole brain | .a | 4210 to 4407 | 207 to 10 | 198/207 (95 %) | 0 diff (100 %id) | |||
| TI_154100690 | .a | 4259 to 5090 | 913 to 84 | AAA | Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) | 830/830 (100 %) | 14 diff (98.4 %id) | ||
| T87668 | liver and spleen | .a | 4299 to 4494 | 1 to 200 | 200/200 (100 %) | 4 diff (98.0 %id) | |||
| W02425 | liver and spleen | .a | 4299 to 4841 | 1 to 544 | fully sequenced, | 544/544 (100 %) | 5 diff (99.1 %id) | ||
| AA203683 | liver and spleen | .a | 4299 to 4929 | 1 to 621 | 621/625 (99 %) | 14 diff (97.8 %id) | |||
| BU608769 | Human Lung Epithelial cells, lung | .a | 4301 to 5108 | 806 to 1 | 806/806 (100 %) | 2 diff (99.8 %id) | |||
| BU861297 | mixed (pool of 40 RNAs) | .a | 4317 to 5055 | 1 to 750 | AAA | 750/793 (94 %) | 15 diff (98.2 %id) | ||
| BG282803 | adenocarcinoma, cell line, Prostate | .a | 4323 to 5107 | 1 to 775 | 775/977 (79 %) | 20 diff (98.0 %id) | |||
| AA329323 | .a | 4326 to 4643 | 1 to 319 | 319/319 (100 %) | 1 diff (99.7 %id) | ||||
| AW958128 | .a | 4327 to 4644 | 1 to 318 | 318/476 (66 %) | 1 diff (99.8 %id) | ||||
| BQ019007 | lung, Metastatic Chondrosarcoma | .a | 4338 to 5108 | 770 to 1 | 770/770 (100 %) | 1 diff (99.9 %id) | |||
| DA400526 | thalamus | .a | 4357 to 4902 | 2 to 548 | capped | 547/547 (100 %) | 1 diff (99.9 %id) | ||
| AA011264 | liver and spleen | .a | 4381 to 4726 | 10 to 361 | fully sequenced, | 352/361 (97 %) | 6 diff (98.4 %id) | ||
| BE172039 | head_neck | .a | 4406 to 4725 | 325 to 7 | Submitted on the opposite strand | 319/408 (78 %) | 0 diff (100 %id) | ||
| N28958 | melanocyte | .a | 4408 to 4811 | 1 to 408 | 408/502 (81 %) | 11 diff (97.9 %id) | |||
| FN080889 | breast carcinoma | .a | 4420 to 4521 | 105 to 1 | Submitted on the opposite strand | 105/105 (100 %) | 5 diff (95.3 %id) | ||
| AA025995 | heart | .a | 4450 to 4814 | 1 to 370 | fully sequenced, | 370/370 (100 %) | 6 diff (98.4 %id) | ||
| W27827 | eye, retina | .a | 4453 to 4954 | 20 to 526 | 507/572 (88 %) | 14 diff (97.6 %id) | |||
| BF678730 | Prostate | .a | 4477 to 5112 | 1 to 635 | 635/749 (84 %) | 14 diff (98.2 %id) | |||
| CA441492 | Fibrosarcoma | .a | 4492 to 5108 | 617 to 1 | 617/617 (100 %) | 0 diff (100 %id) | |||
| AA026694 | heart | .a | 4497 to 4726 | 1 to 231 | fully sequenced, | 231/231 (100 %) | 0 diff (100 %id) | ||
| CB163112 | Liver | .a | 4513 to 5082 | 570 to 1 | Submitted on the opposite strand | 570/570 (100 %) | 0 diff (100 %id) | ||
| T70131 | lung | .a | 4519 to 4949 | 1 to 439 | 439/443 (99 %) | 15 diff (96.7 %id) | |||
| BF001583 | colon, colon tumor, RER+ | .a | 4532 to 5092 | 561 to 1 | 561/561 (100 %) | 2 diff (99.7 %id) | |||
| AW195564 | pooled | .a | 4543 to 5091 | 549 to 1 | 549/549 (100 %) | 0 diff (100 %id) | |||
| AI927330 | Kidney | .a | 4545 to 5090 | 547 to 1 | 547/547 (100 %) | 7 diff (98.8 %id) | |||
| DB310057. matches multiple genes | hippocampus | .a | 4551 to 5090 | 540 to 1 | also hits gene foger | 540/540 (100 %) | 1 diff (99.9 %id) | ||
| AI470245 | pooled | .a | 4551 to 5089 | 534 to 1 | 534/535 (99 %) | 19 diff (96.5 %id) | |||
| AI193021 | lung | .a | 4561 to 5089 | 529 to 1 | 529/532 (99 %) | 0 diff (100 %id) | |||
| BM931496 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 4562 to 4831 | 1 to 270 | 270/271 (99 %) | 1 diff (99.7 %id) | |||
| AW006880 | Kidney | .a | 4574 to 5090 | 518 to 1 | 518/518 (100 %) | 1 diff (99.9 %id) | |||
| AW466909 | 2 pooled tumors (clear cell type), Kidney | .a | 4575 to 5059 | 485 to 1 | 485/485 (100 %) | 4 diff (99.2 %id) | |||
| H54115 | liver and spleen | .a | 4579 to 5024 | 453 to 1 | Submitted on the opposite strand | 453/455 (99 %) | 23 diff (95.0 %id) | ||
| AI261929 | Kidney | .a | 4631 to 5092 | 462 to 1 | 462/462 (100 %) | 0 diff (100 %id) | |||
| AI830864 | lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) | .a | 4631 to 5103 | 474 to 1 | 474/474 (100 %) | 3 diff (99.4 %id) | |||
| BF431697 | Kidney | .a | 4632 to 5093 | 462 to 1 | 462/462 (100 %) | 8 diff (98.3 %id) | |||
| AI141446 | heart | .a | 4634 to 5091 | 458 to 1 | 458/458 (100 %) | 0 diff (100 %id) | |||
| BE857409 | brain, glioblastoma (pooled) | .a | 4641 to 5086 | 446 to 1 | 446/446 (100 %) | 2 diff (99.6 %id) | |||
| AA680108 | liver and spleen | .a | 4643 to 5090 | 449 to 1 | 449/449 (100 %) | 5 diff (98.9 %id) | |||
| DA121096 | cerebellum | .a | 4647 to 5092 | 2 to 447 | capped | 446/446 (100 %) | 0 diff (100 %id) | ||
| AI248492 | liver and spleen | .a | 4653 to 5092 | 440 to 1 | 440/440 (100 %) | 0 diff (100 %id) | |||
| AW295781 | .a | 4682 to 5107 | 426 to 1 | 426/436 (97 %) | 3 diff (99.4 %id) | ||||
| BM716759 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 4687 to 5090 | 1 to 404 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) | 404/404 (100 %) | 0 diff (100 %id) | |
| AI635710 | Kidney | .a | 4692 to 5090 | 397 to 1 | 397/397 (100 %) | 4 diff (99.0 %id) | |||
| AW299645 | Kidney | .a | 4694 to 5102 | 409 to 1 | 409/409 (100 %) | 3 diff (99.3 %id) | |||
| AA026600 | heart | .a | 4696 to 5091 | 395 to 1 | fully sequenced, | 395/395 (100 %) | 6 diff (98.5 %id) | ||
| AA723458 | heart | .a | 4701 to 5109 | 409 to 1 | 409/412 (99 %) | 7 diff (98.4 %id) | |||
| AA011345 | liver and spleen | .a | 4711 to 5090 | 385 to 1 | fully sequenced, | 385/385 (100 %) | 7 diff (98.2 %id) | ||
| AI610777 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .a | 4713 to 5111 | 399 to 1 | 399/399 (100 %) | 2 diff (99.5 %id) | |||
| AW613877 | 2 pooled high-grade transitional celltumors, genitourinary tract | .a | 4715 to 5091 | 377 to 1 | 377/377 (100 %) | 0 diff (100 %id) | |||
| AW182269 | pooled | .a | 4718 to 5111 | 394 to 1 | 394/394 (100 %) | 6 diff (98.5 %id) | |||
| AI141085 | lung | .a | 4719 to 5110 | 392 to 1 | 392/392 (100 %) | 1 diff (99.8 %id) | |||
| AA522637 | metastatic prostate bone lesion | .a | 4726 to 5113 | 390 to 1 | 390/391 (99 %) | 3 diff (99.3 %id) | |||
| R52395 | whole brain | .a | 4730 to 5086 | 365 to 1 | 365/367 (99 %) | 21 diff (94.3 %id) | |||
| AA887169 | metastatic prostate bone lesion | .a | 4733 to 5101 | 369 to 1 | 369/369 (100 %) | 4 diff (99.0 %id) | |||
| AA522666 | metastatic prostate bone lesion | .a | 4737 to 5115 | 379 to 1 | 379/379 (100 %) | 7 diff (98.2 %id) | |||
| AI264097 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 4743 to 5106 | 364 to 1 | 364/364 (100 %) | 0 diff (100 %id) | |||
| N67852 | melanocyte | .a | 4747 to 5095 | 352 to 1 | 352/352 (100 %) | 8 diff (97.8 %id) | |||
| BM724126 | eye, fetal eye | .a | 4747 to 5093 | 347 to 1 | Submitted on the opposite strand | 347/355 (97 %) | 0 diff (100 %id) | ||
| TI_151757336 | .a | 4750 to 5093 | 70 to 413 | Submitted on the opposite strand | 344/967 (35 %) | 2 diff (99.8 %id) | |||
| AA669439 | lung, lung carcinoma | .a | 4775 to 5055 | 280 to 1 | 280/280 (100 %) | 1 diff (99.7 %id) | |||
| AA025936 | heart | .a | 4784 to 5118 | 336 to 1 | fully sequenced, | 336/336 (100 %) | 1 diff (99.8 %id) | ||
| AA235280 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 4790 to 5084 | 298 to 4 | 295/298 (98 %) | 0 diff (100 %id) | |||
| AA927208 | pooled | .a | 4790 to 5107 | 317 to 1 | 317/317 (100 %) | 2 diff (99.4 %id) | |||
| AA723696 | pooled | .a | 4807 to 5090 | 284 to 1 | 284/284 (100 %) | 4 diff (98.6 %id) | |||
| T82421 | lung | .a | 4809 to 5065 | 255 to 1 | 255/255 (100 %) | 3 diff (98.9 %id) | |||
| N73589 | liver and spleen | .a | 4811 to 5086 | 279 to 1 | fully sequenced, | 279/279 (100 %) | 9 diff (96.8 %id) | ||
| DA105175 | cerebellum | .a | 4813 to 5363 | 2 to 552 | capped | 551/551 (100 %) | 1 diff (99.9 %id) | ||
| DA403162 | thalamus | .a | 4813 to 5132 | 2 to 320 | capped | 319/319 (100 %) | 1 diff (99.7 %id) | ||
| AA777894 | liver and spleen | .a | 4830 to 5086 | 257 to 1 | 257/257 (100 %) | 1 diff (99.7 %id) | |||
| AA458578 | .a | 4831 to 5107 | 277 to 1 | 277/277 (100 %) | 1 diff (99.7 %id) | ||||
| AI202377 | Prostate | .a | 4833 to 5110 | 278 to 1 | 278/278 (100 %) | 2 diff (99.3 %id) | |||
| AI373225 | Kidney | .a | 4842 to 5101 | 260 to 1 | 260/260 (100 %) | 0 diff (100 %id) | |||
| AI699943 | pooled germ cell tumors | .a | 4845 to 5096 | 252 to 1 | 252/252 (100 %) | 2 diff (99.3 %id) | |||
| DA809837 | brain | .a | 4868 to 5232 | 2 to 366 | capped | 365/365 (100 %) | 0 diff (100 %id) | ||
| BM674388 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 4873 to 5108 | 236 to 1 | fully sequenced, | Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) | 236/236 (100 %) | 0 diff (100 %id) | |
| AA777465 | liver and spleen | .a | 4880 to 5086 | 207 to 1 | 207/207 (100 %) | 0 diff (100 %id) | |||
| AA327282 | colon | .a | 4891 to 5090 | 1 to 200 | 200/200 (100 %) | 0 diff (100 %id) | |||
| AW952304 | .a | 4906 to 5090 | 1 to 185 | AAA | Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) | 185/185 (100 %) | 0 diff (100 %id) | ||
| AA775172 | lung | .a | 4912 to 5059 | 148 to 1 | 148/148 (100 %) | 0 diff (100 %id) | |||
| AI971337 | Prostate | .a | 4915 to 5091 | 177 to 1 | 177/177 (100 %) | 3 diff (98.4 %id) | |||
| DA759940 | .a | 4956 to 5251 | 2 to 297 | capped | 296/296 (100 %) | 0 diff (100 %id) | |||
| DA127964 | cerebellum | .a | 4994 to 5605 | 2 to 616 | capped | 615/615 (100 %) | 4 diff (99.4 %id) | ||
| AA807359 | brain, substantia nigra | .a | 5006 to 5090 | 85 to 1 | 85/85 (100 %) | 0 diff (100 %id) | |||
| DB220184 | trachea | .a | 5007 to 5232 | 2 to 229 | capped | 228/228 (100 %) | 2 diff (99.2 %id) | ||
| AI694733 | carcinoid, lung | .a | 5051 to 5370 | 1 to 319 | Submitted on the opposite strand | 319/319 (100 %) | 3 diff (99.1 %id) | ||
| DA798209 | brain | .a | 5088 to 5657 | 2 to 571 | tiling clone, capped | 570/570 (100 %) | 0 diff (100 %id) | ||
| BF947711 | nervous_normal | .a | 5097 to 5267 | 171 to 1 | 171/212 (80 %) | 1 diff (99.6 %id) | |||
| BF947673 | nervous_normal | .a | 5110 to 5267 | 160 to 1 | 160/160 (100 %) | 3 diff (98.2 %id) | |||
| DA721262 | .a | 5110 to 5653 | 2 to 547 | capped | 546/547 (99 %) | 3 diff (99.5 %id) | |||
| CR596491 | fetal brain | .a | 5132 to 8432 | 1 to 3301 | tiling clone, | 3301/3301 (100 %) | 0 diff (100 %id) | ||
| AL536554 | brain, fetal brain | .a | 5132 to 6061 | 1 to 924 | 924/924 (100 %) | 34 diff (96.4 %id) | |||
| DA399740 | thalamus | .a | 5157 to 5722 | 2 to 567 | capped | 566/566 (100 %) | 3 diff (99.5 %id) | ||
| DA298006 | hippocampus | .a | 5218 to 5789 | 2 to 573 | capped | 572/572 (100 %) | 0 diff (100 %id) | ||
| DA519095 | brain | .a | 5281 to 5832 | 2 to 553 | capped | 552/552 (100 %) | 0 diff (100 %id) | ||
| DA744208 | .a | 5316 to 5858 | 2 to 545 | capped | 544/544 (100 %) | 3 diff (99.5 %id) | |||
| DA505801 | brain | .a | 5414 to 5977 | 2 to 566 | capped | 565/565 (100 %) | 2 diff (99.7 %id) | ||
| DA804970 | brain | .a | 5440 to 5947 | 2 to 509 | capped | 508/508 (100 %) | 2 diff (99.7 %id) | ||
| DA776915 | brain | .a | 5448 to 6020 | 2 to 574 | capped | 573/573 (100 %) | 2 diff (99.7 %id) | ||
| DA125893 | cerebellum | .a | 5478 to 6054 | 2 to 578 | capped | 577/577 (100 %) | 0 diff (100 %id) | ||
| R06676 | liver and spleen | .a | 5556 to 5837 | 1 to 291 | 291/300 (97 %) | 15 diff (95.0 %id) | |||
| DA770862 | brain | .a | 5568 to 6019 | 2 to 453 | capped | 452/452 (100 %) | 0 diff (100 %id) | ||
| DA771165 | brain | .a | 5571 to 6130 | 2 to 561 | capped | 560/560 (100 %) | 1 diff (99.9 %id) | ||
| CN411821 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 5587 to 6188 | 1 to 601 | 601/601 (100 %) | 2 diff (99.7 %id) | |||
| DA252005 | caudate nucleus | .a | 5609 to 6125 | 2 to 518 | capped | 517/517 (100 %) | 2 diff (99.7 %id) | ||
| DA789230 | brain | .a | 5611 to 6188 | 2 to 580 | capped | 579/579 (100 %) | 3 diff (99.5 %id) | ||
| AA865857 | pooled germ cell tumors | .a | 5671 to 6019 | 357 to 6 | 352/357 (98 %) | 0 diff (100 %id) | |||
| DA538198 | Kidney | .a | 5689 to 6285 | 2 to 598 | capped | 597/597 (100 %) | 2 diff (99.7 %id) | ||
| DA732786 | .a | 5704 to 6454 | 2 to 767 | capped | 766/811 (94 %) | 30 diff (96.4 %id) | |||
| DA493614 | brain | .a | 5718 to 6213 | 2 to 498 | capped | 497/497 (100 %) | 4 diff (99.2 %id) | ||
| BM450162 | melanotic melanoma, skin | .a | 5949 to 6848 | 1 to 912 | 912/1053 (86 %) | 23 diff (97.9 %id) | |||
| BX451725 | brain, fetal brain | .a | 5958 to 6887 | 1 to 918 | 918/918 (100 %) | 31 diff (96.7 %id) | |||
| DA174698 | amygdala | .a | 6031 to 6566 | 2 to 537 | capped | 536/536 (100 %) | 1 diff (99.9 %id) | ||
| DA285656 | corpus callosum | .a | 6244 to 6733 | 2 to 491 | capped | 490/490 (100 %) | 1 diff (99.8 %id) | ||
| DA279966 | corpus callosum | .a | 6304 to 6871 | 2 to 569 | capped | 568/568 (100 %) | 1 diff (99.9 %id) | ||
| BF130205 | hypernephroma, Kidney | .a | 6396 to 6973 | 1 to 570 | 570/811 (70 %) | 36 diff (95.6 %id) | |||
| BX477901 | .a | 6432 to 6928 | 1 to 497 | 497/497 (100 %) | 1 diff (99.8 %id) | ||||
| N20570 | melanocyte | .a | 6432 to 6611 | 350 to 172 | 179/350 (51 %) | 0 diff (100 %id) | |||
| BG433889 | Kidney | .a | 6482 to 7217 | 1 to 740 | 740/840 (88 %) | 24 diff (97.2 %id) | |||
| BU189172 | melanotic melanoma, skin | .a | 6487 to 7320 | 1 to 841 | 841/841 (100 %) | 14 diff (98.4 %id) | |||
| DA009377 | adrenal gland | .a | 6497 to 7053 | 2 to 558 | capped | 557/562 (99 %) | 2 diff (99.7 %id) | ||
| AL534493 | brain, fetal brain | .a | 6577 to 7375 | 1 to 801 | 801/801 (100 %) | 7 diff (99.2 %id) | |||
| BM697669 | eye, fetal eyes | .a | 6791 to 7250 | 1 to 460 | 460/460 (100 %) | 0 diff (100 %id) | |||
| BX433254 | brain, fetal brain | .a | 6817 to 7670 | 853 to 1 | 853/854 (99 %) | 3 diff (99.7 %id) | |||
| Z44547 | brain, total brain | .a | 6830 to 7091 | 1 to 262 | 262/262 (100 %) | 0 diff (100 %id) | |||
| BG565914 | Liver | .a | 6862 to 7588 | 1 to 740 | 740/745 (99 %) | 27 diff (96.4 %id) | |||
| BF738151 | bladder_tumor | .a | 6864 to 7155 | 13 to 306 | 294/306 (96 %) | 6 diff (98.1 %id) | |||
| BF822549 | kidney_tumor | .a | 6864 to 7155 | 13 to 306 | 294/306 (96 %) | 6 diff (98.1 %id) | |||
| BI860472 | breast, mammary adenocarcinoma, cell line | .a | 6871 to 7599 | 1 to 730 | 730/730 (100 %) | 9 diff (98.8 %id) | |||
| TI_57189426 | .a | 6871 to 7599 | 49 to 778 | 730/730 (100 %) | 9 diff (98.8 %id) | ||||
| BM757845 | stomach | .a | 6875 to 7449 | 1 to 575 | 575/575 (100 %) | 0 diff (100 %id) | |||
| BM783736 | stomach | .a | 6875 to 7583 | 1 to 709 | 709/709 (100 %) | 0 diff (100 %id) | |||
| H19222 | whole brain | .a | 6876 to 7309 | 1 to 442 | Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) | 442/445 (99 %) | 12 diff (97.4 %id) | ||
| H23299 | whole brain | .a | 6912 to 7409 | 1 to 503 | 503/504 (99 %) | 10 diff (98.1 %id) | |||
| Z45896 | brain, total brain | .a | 6917 to 7147 | 1 to 231 | 231/231 (100 %) | 0 diff (100 %id) | |||
| W27737 | eye, retina | .a | 6924 to 7389 | 25 to 489 | 465/523 (88 %) | 26 diff (95.1 %id) | |||
| BG334421 | melanotic melanoma, skin | .a | 7081 to 7792 | 1 to 719 | 719/929 (77 %) | 28 diff (97.0 %id) | |||
| H65137 | nose, olfactory epithelium | .a | 7133 to 7569 | 1 to 441 | 441/446 (98 %) | 26 diff (94.2 %id) | |||
| AA425069 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 7138 to 7588 | 1 to 451 | 451/451 (100 %) | 0 diff (100 %id) | |||
| AA089790 | .a | 7180 to 7446 | 1 to 268 | 268/269 (99 %) | 10 diff (96.3 %id) | ||||
| AL565536 | brain, fetal brain | .a | 7586 to 8406 | 856 to 36 | 821/860 (95 %) | 0 diff (100 %id) | |||
| DB364413 | .a | 7886 to 8461 | 573 to 1 | 573/575 (99 %) | 12 diff (98.0 %id) | ||||
| DB317092 | brain | .a | 7919 to 8473 | 555 to 1 | tiling clone, | 555/555 (100 %) | 0 diff (100 %id) | ||
| DB295215 | adrenal gland | .a | 7923 to 8461 | 539 to 1 | 539/539 (100 %) | 0 diff (100 %id) | |||
| H19223 | whole brain | .a | 8036 to 8471 | 469 to 13 | AAA | Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) | 457/459 (99 %) | 28 diff (93.9 %id) | |
| H23185 | whole brain | .a | 8069 to 8478 | 423 to 2 | 422/480 (87 %) | 0 diff (100 %id) | |||
| Z41523 | brain, total brain | .a | 8198 to 8461 | 264 to 1 | 264/264 (100 %) | 0 diff (100 %id) | |||
| H65091 | nose, olfactory epithelium | .a | 8286 to 8441 | 156 to 1 | 156/156 (100 %) | 0 diff (100 %id) | |||
| NM_015277.4 | .b | 1 to 8413 | 1 to 8413 | exact | RefSeq, | 8413/8413 (100 %) | 0 diff (100 %id) | ||
| AB071179 | .b | 161 to 5030 | 1 to 4871 | tiling clone, | 4871/4871 (100 %) | 3 diff (100.0 %id) | |||
| BC000621 | Skin, melanotic melanoma. | .b | 575 to 3575 | 1 to 3001 | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 3001/3001 (100 %) | 0 diff (100 %id) | |
| BC019345 | Uterus, endometrium adenocarcinoma | .b | 575 to 3575 | 1 to 3001 | available from MGC, AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 3001/3001 (100 %) | 0 diff (100 %id) | |
| BM557441 | melanotic melanoma, skin | .b | 592 to 1469 | 22 to 913 | 892/1076 (82 %) | 32 diff (97.1 %id) | |||
| BG490588 | large cell carcinoma, lung | .b | 879 to 1592 | 1 to 721 | 717/848 (84 %) | 20 diff (97.7 %id) | |||
| AW996429 | breast_normal | .b | 994 to 1388 | 1 to 395 | 395/395 (100 %) | 4 diff (99.0 %id) | |||
| DA244881 | brain | .b | 1107 to 1637 | 2 to 532 | capped | 531/531 (100 %) | 0 diff (100 %id) | ||
| DA046787 | .b | 1146 to 1922 | 2 to 778 | capped | 777/785 (98 %) | 1 diff (99.9 %id) | |||
| BG770416 | melanotic melanoma, high MDR (cell line), skin | .b | 1154 to 2058 | 1 to 902 | 902/950 (94 %) | 22 diff (97.7 %id) | |||
| CD655521 | Embryonic Stem cells | .b | 1249 to 2058 | 5 to 813 | 809/814 (99 %) | 11 diff (98.7 %id) | |||
| DA092274 | cerebellum | .b | 1260 to 1825 | 2 to 568 | capped | 567/567 (100 %) | 6 diff (99.0 %id) | ||
| BF196851 | brain, glioblastoma (pooled) | .b | 1276 to 1772 | 497 to 1 | 497/497 (100 %) | 0 diff (100 %id) | |||
| BQ643568 | hepatocellular carcinoma, cell line, Liver | .c | 1 to 359 | 1 to 359 | tiling clone, | 359/1302 (27 %) | 2 diff (99.9 %id) | ||
| BC032597 | Skin, melanotic melanoma. | .c | 13 to 3351 | 11 to 3351 | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 3341/3341 (100 %) | 10 diff (99.8 %id) | |
| BM453891 | melanotic melanoma, skin | .c | 14 to 821 | 1 to 813 | 813/879 (92 %) | 17 diff (98.1 %id) | |||
| DR003384 | fetal brain | .c | 21 to 364 | 1 to 345 | 345/609 (56 %) | 12 diff (98.1 %id) | |||
| BG122821 | adenocarcinoma, cell line, Liver | .c | 526 to 1235 | 1 to 731 | 645/964 (66 %) | 48 diff (95.1 %id) | |||
| AY112984 | .d | 1 to 3411 | 1 to 3410 | A44P | tiling clone, | 3410/3410 (100 %) | 2 diff (100.0 %id) | ||
| NM_001144968.1 | .d | 1 to 8378 | 1 to 8378 | exact | RefSeq, | 8378/8378 (100 %) | 0 diff (100 %id) | ||
| BF965237 | muscle (skeletal) | .e | 1 to 329 | 1 to 329 | tiling clone, | 329/701 (46 %) | 4 diff (99.5 %id) | ||
| DQ181796 | .e | 15 to 3431 | 1 to 3417 | exact | tiling clone, | 3417/3417 (100 %) | 0 diff (100 %id) | ||
| NM_001144971.1 | .e | 15 to 8420 | 1 to 8406 | exact | RefSeq, | 8406/8406 (100 %) | 0 diff (100 %id) | ||
| BF678906 | Prostate | .f | 1 to 653 | 1 to 649 | tiling clone, AAA | 649/649 (100 %) | 11 diff (98.4 %id) | ||
| NM_001144969.1 | .f | 15 to 8332 | 1 to 8318 | exact | RefSeq, | 8318/8318 (100 %) | 0 diff (100 %id) | ||
| AY112985 | .f | 19 to 3365 | 9 to 3354 | A44P | tiling clone, | 3346/3354 (99 %) | 9 diff (99.8 %id) | ||
| AY112983 | .g | 1 to 3421 | 1 to 3420 | A18P | tiling clone, | 3420/3420 (100 %) | 2 diff (100.0 %id) | ||
| NM_001144965.1 | .g | 1 to 8388 | 1 to 8388 | exact | RefSeq, | 8388/8388 (100 %) | 0 diff (100 %id) | ||
| DC381911 | placenta | .h | 1 to 554 | 1 to 554 | tiling clone, | 554/554 (100 %) | 0 diff (100 %id) | ||
| AY243319 | lung | .h | 14 to 431 | 1 to 418 | 418/418 (100 %) | 0 diff (100 %id) | |||
| DC363885 | .h | 14 to 576 | 1 to 563 | 563/563 (100 %) | 0 diff (100 %id) | ||||
| NM_001144966.1 | .h | 14 to 8313 | 1 to 8300 | exact | RefSeq, | 8300/8300 (100 %) | 0 diff (100 %id) | ||
| DC416485 | trachea | .h | 17 to 577 | 1 to 561 | 561/561 (100 %) | 0 diff (100 %id) | |||
| DC299395 | .h | 47 to 609 | 1 to 563 | 563/563 (100 %) | 0 diff (100 %id) | ||||
| AK300444 | placenta | .h | 50 to 3351 | 1 to 3302 | N524S | tiling clone, | 3302/3307 (99 %) | 4 diff (99.9 %id) | |
| DC299077 | .h | 50 to 610 | 1 to 562 | 562/562 (100 %) | 1 diff (99.9 %id) | ||||
| DC300340 | .h | 50 to 617 | 1 to 568 | 568/568 (100 %) | 0 diff (100 %id) | ||||
| DC300402 | .h | 50 to 578 | 1 to 529 | 529/529 (100 %) | 0 diff (100 %id) | ||||
| DW447811 | Liver | .h | 50 to 236 | 17 to 203 | 187/211 (88 %) | 3 diff (98.6 %id) | |||
| BP237554 | Liver | .h | 50 to 672 | 1 to 623 | 623/623 (100 %) | 0 diff (100 %id) | |||
| CB108765 | Liver | .h | 50 to 650 | 1 to 601 | 601/601 (100 %) | 2 diff (99.7 %id) | |||
| DC381620 | placenta | .h | 50 to 640 | 1 to 591 | 591/593 (99 %) | 1 diff (99.9 %id) | |||
| DC381975 | placenta | .h | 50 to 590 | 1 to 541 | 541/541 (100 %) | 0 diff (100 %id) | |||
| DC382211 | placenta | .h | 50 to 595 | 1 to 547 | 547/547 (100 %) | 1 diff (99.9 %id) | |||
| DC382536 | placenta | .h | 50 to 687 | 1 to 638 | 638/638 (100 %) | 1 diff (99.9 %id) | |||
| DC383549 | Prostate | .h | 50 to 610 | 1 to 561 | 561/561 (100 %) | 0 diff (100 %id) | |||
| BP364037 | lung | .h | 50 to 631 | 1 to 582 | 582/582 (100 %) | 1 diff (99.9 %id) | |||
| DC417164 | trachea | .h | 58 to 637 | 1 to 580 | 580/580 (100 %) | 1 diff (99.9 %id) | |||
| BG252484 | adenocarcinoma, cell line, Liver | .h | 62 to 743 | 1 to 688 | 648/996 (65 %) | 27 diff (97.3 %id) | |||
| DC358947 | lung | .h | 64 to 625 | 1 to 562 | 562/562 (100 %) | 0 diff (100 %id) | |||
| CN314402 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .h | 66 to 795 | 1 to 731 | 731/735 (99 %) | 2 diff (99.8 %id) | |||
| BX361117 | Placenta Cot 25-normalized | .h | 67 to 1101 | 1 to 1032 | 1032/1032 (100 %) | 34 diff (96.8 %id) | |||
| Z20619 | .h | 71 to 287 | 1 to 217 | 217/219 (99 %) | 7 diff (96.9 %id) | ||||
| AF210730 | .h | 101 to 3346 | 1 to 3246 | exact | tiling clone, AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 3246/3246 (100 %) | 2 diff (100.0 %id) | |
| TI_57228572 | .h | 108 to 991 | 52 to 934 | 883/897 (98 %) | 15 diff (98.4 %id) | ||||
| BI869524 | adenocarcinoma, cell line, Liver | .h | 109 to 991 | 1 to 882 | 882/896 (98 %) | 15 diff (98.4 %id) | |||
| DC414659 | trachea | .h | 165 to 752 | 1 to 588 | 588/588 (100 %) | 2 diff (99.7 %id) | |||
| DC415969 | trachea | .i | 1 to 500 | 6 to 505 | tiling clone, | 505/505 (100 %) | 0 diff (100 %id) | ||
| AL137469 | testis | .i | 186 to 2952 | 1 to 2767 | tiling clone, available from DKFZ, AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 2767/2767 (100 %) | 0 diff (100 %id) | |
| BY799685 | eye | .i | 657 to 1231 | 1 to 574 | 574/574 (100 %) | 2 diff (99.7 %id) | |||
| DA243227 | brain | .j | 1 to 589 | 2 to 590 | tiling clone, capped | 589/589 (100 %) | 2 diff (99.7 %id) | ||
| AF385931 | .j | 62 to 3659 | 1 to 3599 | tiling clone, AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 3599/3599 (100 %) | 3 diff (100.0 %id) | ||
| NM_001144964.1 | .j | 62 to 8497 | 1 to 8436 | RefSeq, | 8436/8436 (100 %) | 0 diff (100 %id) | |||
| BE000802 | breast_normal | .j | 124 to 368 | 282 to 32 | Submitted on the opposite strand | 251/295 (85 %) | 0 diff (100 %id) | ||
| BE000845 | breast_normal | .j | 124 to 354 | 232 to 2 | Submitted on the opposite strand | 231/245 (94 %) | 0 diff (100 %id) | ||
| DA819220 | .k | 1 to 554 | 2 to 555 | tiling clone, capped | 554/554 (100 %) | 1 diff (99.9 %id) | |||
| NM_001144970.1 | .k | 15 to 8360 | 1 to 8346 | RefSeq, | 8346/8346 (100 %) | 0 diff (100 %id) | |||
| BP350606 | .k | 15 to 597 | 1 to 583 | 583/583 (100 %) | 1 diff (99.9 %id) | ||||
| DA220385 | brain | .k | 16 to 566 | 2 to 552 | capped | 551/551 (100 %) | 0 diff (100 %id) | ||
| DA248109 | brain | .k | 16 to 598 | 2 to 584 | capped | 583/583 (100 %) | 0 diff (100 %id) | ||
| DA457548 | tongue, tumor tissue | .k | 16 to 456 | 2 to 442 | capped | 441/441 (100 %) | 0 diff (100 %id) | ||
| DA183003 | amygdala | .k | 18 to 566 | 2 to 550 | capped | 549/549 (100 %) | 1 diff (99.9 %id) | ||
| DA328074 | hippocampus | .k | 22 to 518 | 2 to 499 | capped | 498/512 (97 %) | 2 diff (99.7 %id) | ||
| DA216983 | brain | .k | 33 to 513 | 2 to 486 | capped | 485/485 (100 %) | 5 diff (99.0 %id) | ||
| AK294963 | brain | .k | 51 to 3726 | 1 to 3680 | K22R L166R E185G A449K V450A ... | tiling clone, | 3678/3680 (99 %) | 7 diff (99.9 %id) | |
| DC323126 | brain | .k | 51 to 612 | 1 to 562 | 562/562 (100 %) | 0 diff (100 %id) | |||
| DC342827 | thalamus | .k | 51 to 619 | 1 to 569 | 569/570 (99 %) | 2 diff (99.7 %id) | |||
| BP218498 | caudate nucleus | .k | 51 to 518 | 1 to 468 | 468/580 (80 %) | 6 diff (99.0 %id) | |||
| DA226067 | brain | .k | 52 to 566 | 2 to 516 | capped | 515/515 (100 %) | 1 diff (99.9 %id) | ||
| AY243318 | lung | .k | 60 to 538 | 1 to 479 | 479/479 (100 %) | 1 diff (99.8 %id) | |||
| AB007899 | brain | .k | 100 to 4977 | 1 to 4879 | tiling clone, available from KIAA, | 4879/4879 (100 %) | 3 diff (100.0 %id) | ||
| DA192505 | amygdala | .k | 232 to 791 | 2 to 561 | capped | 560/560 (100 %) | 4 diff (99.3 %id) | ||
| DA100948 | cerebellum | .k | 252 to 838 | 2 to 588 | capped | 587/587 (100 %) | 0 diff (100 %id) | ||
| DB229842 | trachea | .k | 268 to 839 | 2 to 573 | capped | 572/572 (100 %) | 0 diff (100 %id) | ||
| DA193303 | amygdala | .k | 318 to 839 | 2 to 523 | capped | 522/522 (100 %) | 0 diff (100 %id) | ||
| AA489302 | .l | 1 to 479 | 1 to 478 | tiling clone, | 478/478 (100 %) | 1 diff (99.8 %id) | |||
| CF121144 | CNCAP(3)T-225 cell line, Prostate | .l | 501 to 1210 | 8 to 717 | tiling clone, | 710/717 (99 %) | 8 diff (98.9 %id) | ||
| TI_154180143 | .l | 501 to 1337 | 76 to 909 | tiling clone, | 834/835 (99 %) | 11 diff (98.7 %id) | |||
| BX497814 | Liver | .l | 1049 to 1540 | 1 to 492 | tiling clone, | 492/492 (100 %) | 8 diff (98.4 %id) | ||
| AA486281 | .l | 1286 to 1734 | 447 to 1 | 447/447 (100 %) | 3 diff (99.4 %id) | ||||
| BM930263 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .l | 1296 to 1739 | 444 to 1 | tiling clone, | Submitted on the opposite strand | 444/447 (99 %) | 2 diff (99.6 %id) | |
| BM683738 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .l | 1297 to 1745 | 1 to 449 | Submitted on the opposite strand | 449/452 (99 %) | 6 diff (98.7 %id) | ||
| BP274300 | Kidney | .m | 1 to 579 | 1 to 581 | tiling clone, | 579/581 (99 %) | 4 diff (99.4 %id) | ||
| AY751751 | Liver | .m | 478 to 1244 | 1 to 767 | tiling clone, | 767/767 (100 %) | 2 diff (99.8 %id) | ||
| AV729150 | hypothalamus | .n | 1 to 406 | 10 to 415 | tiling clone, | 406/415 (97 %) | 7 diff (98.4 %id) | ||
| CD109507 | Human Placenta, placenta | .n | 321 to 1034 | 18 to 745 | tiling clone, | 728/771 (94 %) | 41 diff (94.7 %id) | ||
| AI637786 | pooled germ cell tumors | .n | 750 to 1273 | 524 to 1 | tiling clone, | 524/524 (100 %) | 1 diff (99.9 %id) | ||
| BX501711 | Liver | .n | 849 to 1273 | 57 to 481 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 425/481 (88 %) | 6 diff (98.8 %id) | |
| BF574344 | muscle (skeletal) | .o | 1 to 660 | 1 to 706 | tiling clone, | 706/820 (86 %) | 29 diff (96.5 %id) | ||
| CR598386 | T cells (Jurkat cell line) Cot10-normalized | .o | 430 to 1540 | 1 to 1111 | exact | tiling clone, | 1111/1111 (100 %) | 0 diff (100 %id) | |
| BP238150 | Liver | .p | 1 to 610 | 1 to 610 | R23F | tiling clone, | 610/610 (100 %) | 3 diff (99.6 %id) | |
| DC321782 | brain | .q | 1 to 572 | 1 to 572 | exact | tiling clone, | 572/572 (100 %) | 0 diff (100 %id) | |
| BP329429 | rectum | .r | 1 to 582 | 1 to 582 | exact | tiling clone, | 582/582 (100 %) | 0 diff (100 %id) | |
| TI_57152993 | .s | 1 to 687 | 84 to 774 | 691/936 (73 %) | 14 diff (98.6 %id) | ||||
| BI765101 | pooled colon, kidney, stomach | .s | 7 to 687 | 1 to 685 | tiling clone, | 685/847 (80 %) | 10 diff (98.9 %id) | ||
| BG540188 | lung | .s | 9 to 651 | 1 to 642 | 642/642 (100 %) | 15 diff (97.7 %id) | |||
| BI762849 | pooled colon, kidney, stomach | .s | 19 to 633 | 1 to 636 | 636/966 (65 %) | 38 diff (96.1 %id) | |||
| BI762734 | pooled colon, kidney, stomach | .s | 19 to 777 | 1 to 775 | I41L I44L E49D E58A W59L ... | tiling clone, | 775/784 (98 %) | 36 diff (95.5 %id) | |
| BI762938 | pooled colon, kidney, stomach | .s | 19 to 890 | 1 to 899 | F80S W96L K97E L98T G99W ... | tiling clone, | 899/899 (100 %) | 49 diff (94.6 %id) | |
| TI_57150397 | .s | 19 to 777 | 64 to 838 | I41L I44L E49D E58A W59L ... | 775/847 (91 %) | 44 diff (94.9 %id) | |||
| TI_57150540 | .s | 19 to 890 | 27 to 925 | F80S W96L K97E L98T G99W ... | 899/925 (97 %) | 34 diff (96.4 %id) | |||
| TI_57150318 | .s | 20 to 633 | 59 to 693 | 635/1023 (62 %) | 29 diff (97.2 %id) | ||||
| AI620533 | Prostate | .s | 339 to 736 | 405 to 8 | tiling clone, | 398/405 (98 %) | 0 diff (100 %id) | ||
| AI620532 | Prostate | .s | 393 to 736 | 347 to 4 | 344/347 (99 %) | 0 diff (100 %id) | |||
| AA662143 | normal prostate, Prostate | .s | 401 to 730 | 333 to 8 | tiling clone, | 326/333 (97 %) | 0 diff (100 %id) | ||
| BF514087 | .s | 432 to 758 | 14 to 340 | tiling clone, | Submitted on the opposite strand | 327/352 (92 %) | 11 diff (96.9 %id) | ||
| AW183334 | pooled | .s | 446 to 728 | 313 to 29 | 285/313 (91 %) | 0 diff (100 %id) | |||
| AW193035 | adenocarcinoma, Pancreas | .s | 504 to 728 | 262 to 38 | 225/262 (85 %) | 0 diff (100 %id) | |||
| BP340588 | Spleen | .t | 1 to 581 | 1 to 581 | exact | tiling clone, | 581/581 (100 %) | 0 diff (100 %id) | |
| AK130420 | rectum | .u | 1 to 2066 | 1 to 2066 | exact | tiling clone, available from FLJ, | 2066/2066 (100 %) | 1 diff (100.0 %id) | |
| BQ007027 | Chondrosarcoma, Left Pelvis | .u | 1333 to 2059 | 745 to 19 | G3A E42X R44A I45Y R46P ... | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 727/727 (100 %) | 3 diff (99.6 %id) |
| DC357667 | .va | 1 to 553 | 1 to 553 | exact | tiling clone, | 553/553 (100 %) | 0 diff (100 %id) | ||
| AK091189 | tongue, tumor tissue | .vb | 1 to 2742 | 2 to 2747 | exact | tiling clone, available from FLJ, | 2747/2747 (100 %) | 2 diff (100.0 %id) | |
| DA438772 | tongue, tumor tissue | .vb | 1 to 597 | 2 to 598 | capped | 597/597 (100 %) | 0 diff (100 %id) | ||
| DB313547 | tongue, tumor tissue | .vb | 2208 to 2742 | 535 to 1 | 535/535 (100 %) | 0 diff (100 %id) | |||
| BF673328 | Prostate | .vc | 1 to 139 | 1 to 139 | exact | tiling clone, | 744/900 (82 %) | 43 diff (95.3 %id) | |
| CV373443 | prostate_tumor | .vd | 1 to 271 | 154 to 428 | tiling clone, | 271/428 (63 %) | 6 diff (98.6 %id) | ||
| BY797839 | eye | .vd | 39 to 651 | 1 to 613 | tiling clone, | 613/613 (100 %) | 0 diff (100 %id) | ||
| CV399297 | prostate_tumor | .vd | 162 to 418 | 6 to 263 | 258/263 (98 %) | 20 diff (92.4 %id) | |||
| AY243316 | lung | .vd | 476 to 769 | 1 to 297 | 297/310 (95 %) | 5 diff (98.4 %id) | |||
| AY243314 | lung | .vd | 520 to 927 | 1 to 408 | tiling clone, | 408/408 (100 %) | 1 diff (99.8 %id) | ||
| DC351044 | brain | .vd | 869 to 1281 | 71 to 484 | exact | tiling clone, | 414/484 (85 %) | 6 diff (98.8 %id) | |
| DA646473 | mammary gland | .ve-u | 1 to 772 | 2 to 769 | C28X A50X | tiling clone, capped | 768/776 (98 %) | 6 diff (99.3 %id) | |
| AK096812 | Prostate | .ve-u | 229 to 2744 | 1 to 2516 | D4Y | tiling clone, available from FLJ, | 2516/2516 (100 %) | 2 diff (100.0 %id) | |
| DA877808 | Prostate | .ve-u | 230 to 786 | 2 to 558 | D4Y | capped | 557/557 (100 %) | 1 diff (99.9 %id) | |
| DB361157 | mammary gland | .ve-u | 2182 to 2744 | 562 to 1 | 562/562 (100 %) | 2 diff (99.7 %id) | |||
| DB330211 | Prostate | .ve-u | 2212 to 2744 | 534 to 1 | 534/534 (100 %) | 1 diff (99.9 %id) | |||
| BG480445 | choriocarcinoma, placenta | .vf-u | 1 to 673 | 1 to 708 | tiling clone, | 708/708 (100 %) | 32 diff (95.5 %id) | ||
| CV362614 | ovary | .vf-u | 700 to 997 | 306 to 6 | tiling clone, | Submitted on the opposite strand | 301/314 (95 %) | 0 diff (100 %id) | |
| BX642806 | .vf-u | 750 to 1178 | 1 to 429 | exact | tiling clone, | 429/429 (100 %) | 0 diff (100 %id) | ||
| BG432676 | Kidney | .vf-u | 894 to 1648 | 1 to 766 | 766/776 (98 %) | 44 diff (94.4 %id) | |||
| AW376914 | colon | .vf-u | 1022 to 1632 | 1 to 612 | tiling clone, | 612/612 (100 %) | 5 diff (99.2 %id) | ||
| AW856882 | colon | .vf-u | 1036 to 1223 | 192 to 6 | 187/193 (96 %) | 0 diff (100 %id) | |||
| AW604320 | colon | .vf-u | 1194 to 1822 | 649 to 23 | tiling clone, | 627/649 (96 %) | 0 diff (100 %id) | ||
| AW752814 | colon | .vf-u | 1331 to 1831 | 513 to 13 | tiling clone, | 501/513 (97 %) | 0 diff (100 %id) | ||
| AW752817 | colon | .vf-u | 1365 to 1818 | 454 to 1 | tiling clone, | 454/454 (100 %) | 0 diff (100 %id) | ||
| AI904428 | breast | .vf-u | 1416 to 1817 | 418 to 15 | 404/419 (96 %) | 0 diff (100 %id) | |||
| DA727948 | .vg-u | 1 to 743 | 2 to 744 | exact | tiling clone, capped | 743/744 (99 %) | 1 diff (99.9 %id) | ||
| CK003868 | brain/CNS, Human Brain - Cerebellar Cortex | .vg-u | 12 to 671 | 1 to 661 | exact | 661/661 (100 %) | 3 diff (99.6 %id) | ||
| W03535. matches multiple genes | melanocyte | .vg-u | 25 to 412 | 1 to 385 | S75P V76F R77V W78G S80C ... | also hits gene HPS3 | 385/385 (100 %) | 3 diff (99.3 %id) | |
| CK904399 | Islets of Langerhans, Pancreas | .vg-u | 35 to 612 | 1 to 578 | exact | 578/578 (100 %) | 0 diff (100 %id) | ||
| BM023475 | Islets of Langerhans, Pancreas | .vg-u | 35 to 613 | 1 to 578 | R37I K38* | 578/578 (100 %) | 4 diff (99.4 %id) | ||
| BM023376 | Islets of Langerhans, Pancreas | .vg-u | 51 to 619 | 1 to 569 | R37I K38L G39W | 569/569 (100 %) | 4 diff (99.3 %id) | ||
| DT218192 | brain | .vg-u | 55 to 679 | 1 to 625 | exact | 625/625 (100 %) | 1 diff (99.9 %id) | ||
| AA426629 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .vg-u | 203 to 709 | 14 to 519 | 506/519 (97 %) | 6 diff (98.9 %id) | |||
| BM714082 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .vg-u | 288 to 708 | 1 to 421 | fully sequenced, | Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) | 421/421 (100 %) | 0 diff (100 %id) | |
| AL596790 | human spinal cord | .vg-u | 328 to 941 | 615 to 1 | Submitted on the opposite strand | 615/615 (100 %) | 1 diff (99.9 %id) | ||
| BU943808 | mixed (pool of 40 RNAs) | .vg-u | 349 to 1119 | 1 to 775 | 775/776 (99 %) | 13 diff (98.4 %id) | |||
| BF082988 | colon_normal | .vg-u | 355 to 453 | 101 to 4 | 98/101 (97 %) | 0 diff (100 %id) | |||
| AL121228 | melanoma (MeWo cell line) | .vg-u | 382 to 666 | 112 to 396 | 285/396 (71 %) | 6 diff (98.5 %id) | |||
| BF217451 | brain, glioblastoma | .vg-u | 520 to 1149 | 1 to 614 | 614/876 (70 %) | 27 diff (97.0 %id) | |||
| BM716484 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .vg-u | 586 to 1265 | 690 to 12 | Submitted on the opposite strand | 679/693 (97 %) | 0 diff (100 %id) | ||
| BU738543 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .vg-u | 587 to 1201 | 1 to 614 | Submitted on the opposite strand | 614/614 (100 %) | 4 diff (99.4 %id) | ||
| BM673992 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .vg-u | 587 to 1258 | 1 to 671 | AAA | Submitted on the opposite strand | 671/671 (100 %) | 7 diff (99.0 %id) | |
| BM715529 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .vg-u | 597 to 1265 | 679 to 12 | tiling clone, AAA | Submitted on the opposite strand | 668/690 (96 %) | 0 diff (100 %id) | |
| BE622143 | melanotic melanoma, skin | .vg-u | 625 to 1255 | 1 to 637 | 637/637 (100 %) | 7 diff (99.0 %id) | |||
| BQ214305 | large cell carcinoma, lung | .vg-u | 647 to 1200 | 1 to 559 | 559/1088 (51 %) | 16 diff (98.6 %id) | |||
| FN050713 | breast carcinoma | .vg-u | 652 to 705 | 54 to 1 | Submitted on the opposite strand | 54/55 (98 %) | 0 diff (100 %id) | ||
| BM023118 | Islets of Langerhans, Pancreas | .vg-u | 669 to 1248 | 580 to 1 | 580/580 (100 %) | 1 diff (99.9 %id) | |||
| CK904398 | Islets of Langerhans, Pancreas | .vg-u | 678 to 1248 | 571 to 1 | 571/571 (100 %) | 0 diff (100 %id) | |||
| BM675266 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .vg-u | 678 to 1258 | 599 to 19 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) | 581/581 (100 %) | 0 diff (100 %id) | |
| AI763298 | Kidney | .vg-u | 687 to 1248 | 562 to 1 | 562/569 (98 %) | 5 diff (99.2 %id) | |||
| AL536553 | brain, fetal brain | .vg-u | 688 to 1219 | 532 to 1 | 953/986 (96 %) | 67 diff (93.3 %id) | |||
| AI765473 | 2 pooled tumors (clear cell type), Kidney | .vg-u | 696 to 1250 | 560 to 6 | 555/560 (99 %) | 0 diff (100 %id) | |||
| BX395199 | Neuroblastoma Cot 50-normalized | .vg-u | 697 to 1250 | 155 to 711 | 557/711 (78 %) | 6 diff (99.2 %id) | |||
| DB326220. matches multiple genes | brain | .vg-u | 715 to 1258 | 544 to 1 | also hits gene miriri | 544/544 (100 %) | 1 diff (99.9 %id) | ||
| FN133573 | breast carcinoma | .vg-u | 733 to 838 | 1 to 107 | 107/107 (100 %) | 1 diff (99.1 %id) | |||
| AW663926 | pooled | .vg-u | 735 to 1255 | 526 to 6 | 521/526 (99 %) | 0 diff (100 %id) | |||
| AI805904 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .vg-u | 761 to 1257 | 497 to 1 | 497/497 (100 %) | 0 diff (100 %id) | |||
| AI418006 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .vg-u | 792 to 1258 | 477 to 11 | AAA | Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) | 467/467 (100 %) | 0 diff (100 %id) | |
| AI376713 | .vg-u | 799 to 1250 | 454 to 2 | 453/454 (99 %) | 0 diff (100 %id) | ||||
| BQ030227 | lung, Metastatic Chondrosarcoma | .vg-u | 799 to 1258 | 478 to 19 | AAA | Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) | 460/460 (100 %) | 0 diff (100 %id) | |
| N26256 | melanocyte | .vg-u | 825 to 1248 | 424 to 1 | 424/424 (100 %) | 0 diff (100 %id) | |||
| AI243456 | pooled | .vg-u | 825 to 1258 | 434 to 1 | 434/434 (100 %) | 0 diff (100 %id) | |||
| D44900 | brain | .vg-u | 832 to 1247 | 417 to 1 | Submitted on the opposite strand | 417/417 (100 %) | 1 diff (99.8 %id) | ||
| AA424849 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .vg-u | 832 to 1244 | 418 to 6 | 413/418 (98 %) | 0 diff (100 %id) | |||
| BU945204 | mixed (pool of 40 RNAs) | .vg-u | 836 to 1264 | 1 to 429 | tiling clone, | 429/433 (99 %) | 3 diff (99.4 %id) | ||
| AI358418 | poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus | .vg-u | 840 to 1248 | 409 to 1 | 409/409 (100 %) | 0 diff (100 %id) | |||
| N33507 | melanocyte | .vg-u | 845 to 1260 | 418 to 1 | 418/418 (100 %) | 3 diff (99.3 %id) | |||
| BM023192 | Islets of Langerhans, Pancreas | .vg-u | 854 to 1248 | 395 to 1 | 395/395 (100 %) | 1 diff (99.8 %id) | |||
| N67688. matches multiple genes | melanocyte | .vg-u | 860 to 1260 | 406 to 1 | also hits gene HPS3 | 406/406 (100 %) | 5 diff (98.8 %id) | ||
| AI433991 | adenocarcinoma, Pancreas | .vg-u | 875 to 1260 | 384 to 1 | 384/384 (100 %) | 2 diff (99.5 %id) | |||
| AA975075 | Kidney | .vg-u | 878 to 1261 | 388 to 5 | 384/388 (98 %) | 0 diff (100 %id) | |||
| AA907398 | carcinoid, lung | .vg-u | 894 to 1250 | 359 to 3 | 357/359 (99 %) | 0 diff (100 %id) | |||
| BU680325 | lung, Primary Lung Epithelial Cells | .vg-u | 961 to 1258 | 316 to 19 | AAA | Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) | 298/306 (97 %) | 0 diff (100 %id) | |
| BM713114 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .vg-u | 968 to 1265 | 309 to 12 | Submitted on the opposite strand | 298/309 (96 %) | 0 diff (100 %id) | ||
| AI559921 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .vg-u | 1002 to 1248 | 247 to 1 | 247/247 (100 %) | 0 diff (100 %id) | |||
| BX369797 | Neuroblastoma Cot 50-normalized | .vg-u | 1116 to 1250 | 1 to 136 | 136/139 (97 %) | 3 diff (97.9 %id) | |||
| D11900 | Liver | .vg-u | 1129 to 1250 | 1 to 122 | 122/123 (99 %) | 1 diff (99.2 %id) | |||
| DC336209 | hippocampus | .vh | 1 to 594 | 1 to 594 | tiling clone, | 594/594 (100 %) | 1 diff (99.9 %id) | ||
| DC418883 | trachea | .vh | 36 to 628 | 1 to 593 | tiling clone, | 593/593 (100 %) | 0 diff (100 %id) | ||
| DB247002 | .vh | 323 to 868 | 2 to 548 | exact | tiling clone, capped | 547/547 (100 %) | 1 diff (99.9 %id) | ||
| BU183524 | melanotic melanoma, skin | .vi | 1 to 827 | 12 to 840 | G146R D147G V148M P149S | tiling clone, | 829/878 (94 %) | 9 diff (99.0 %id) | |
| BU839569 | hepatocellular carcinoma, cell line, Liver | .vj | 1 to 752 | 1 to 754 | exact | tiling clone, | 754/937 (80 %) | 25 diff (97.4 %id) | |
| BU189167 | melanotic melanoma, skin | .vk | 1 to 667 | 1 to 667 | exact | tiling clone, | 667/864 (77 %) | 1 diff (99.9 %id) | |
| BG994392 | head_neck | .vl-u | 1 to 561 | 16 to 576 | exact | tiling clone, | 561/576 (97 %) | 6 diff (99.0 %id) | |
| BG996301 | head_neck | .vl-u | 11 to 451 | 1 to 439 | exact | 439/439 (100 %) | 4 diff (99.1 %id) | ||
| DC299844 | .vm | 1 to 555 | 1 to 555 | exact | tiling clone, | 555/555 (100 %) | 0 diff (100 %id) | ||
| AY243313 | lung | .vn | 1 to 172 | 1 to 173 | tiling clone, | 173/185 (93 %) | 4 diff (97.9 %id) | ||
| AY256662 | lung | .vn | 113 to 551 | 1 to 439 | exact | tiling clone, | 439/439 (100 %) | 1 diff (99.8 %id) | |
| CN314399 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .vo | 1 to 488 | 1 to 488 | F49L | tiling clone, | 488/490 (99 %) | 5 diff (99.0 %id) | |
| BF882998 | lung_tumor | .vp-u | -8 to 485 | 1 to 494 | H4R G17N Q20* | tiling clone, | 494/494 (100 %) | 23 diff (95.4 %id) | |
| AY243321 | lung | .vq | 1 to 381 | 1 to 381 | L49F | tiling clone, | 381/381 (100 %) | 8 diff (98.0 %id) | |
| AW948750 | prostate_tumor | .vr-u | 1 to 370 | 7 to 375 | I2L R4T G5S M8* | 369/375 (98 %) | 6 diff (98.4 %id) | ||
| AW948748 | prostate_tumor | .vr-u | 4 to 365 | 17 to 378 | tiling clone, | 362/378 (95 %) | 6 diff (98.5 %id) | ||
| AW948753 | prostate_tumor | .vr-u | 4 to 346 | 8 to 351 | tiling clone, | 344/351 (98 %) | 6 diff (98.3 %id) | ||
| AW025620 | Kidney | .vs | 1 to 314 | 314 to 1 | exact | tiling clone, | 314/314 (100 %) | 0 diff (100 %id) | |
| FN097947 | breast carcinoma | .vt-u | 1 to 103 | 1 to 99 | tiling clone, | 99/101 (98 %) | 5 diff (95.1 %id) | ||
| AI972462 | Prostate | .vt-u | 78 to 284 | 226 to 19 | tiling clone, AAA | Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) | 208/208 (100 %) | 3 diff (98.6 %id) | |
| AV709004 | adrenal gland | Gene NEDD4L, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| DA052588 | Gene NEDD4L, variant not shown | capped | Suspected internal deletion, this clone was ignored | ||||||
| EC476277 | Prostate | Gene NEDD4L, variant not shown | |||||||
| H05550 | whole brain | Gene NEDD4L, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| AW015258 | Gene NEDD4L, variant not shown | AAA | Suspected internal deletion, this clone was ignored | ||||||
| BF436834 | Prostate | Gene NEDD4L, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| BM545141 | ovary (pool of 3) | Gene NEDD4L, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| CD652895 | Embryonic Stem cells | Gene NEDD4L, variant not shown | This clone was ignored | ||||||
| DB374846 | placenta | Gene NEDD4L, variant not shown | This clone was ignored | ||||||
| AU136332 | placenta | Gene NEDD4L, variant not shown | capped | This clone was ignored | |||||
| DA869743 | Prostate | Gene NEDD4L, variant not shown | capped | This clone was ignored | |||||
| DB329847 | Prostate | Gene NEDD4L, variant not shown | This clone was ignored | ||||||
| DC383304 | Prostate | Gene NEDD4L, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| DC426511 | Prostate | Gene NEDD4L, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| TI_154103538 | Gene NEDD4L, variant not shown | AAA | Suspected internal deletion, this clone was ignored | ||||||
| CK725192 | Chondrosarcoma, Left Pubic Bone | Gene NEDD4L, variant not shown | AAA | Suspected internal deletion, this clone was ignored |
| ? | Gene Summary | Gene on genome | mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve-u, .vf-u, .vg-u, .vh, .vi, .vj, .vk, .vl-u, .vm, .vn, .vo, .vp-u, .vq, .vr-u, .vs, .vt-u, .vu-u | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes DCI |